Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: A Randomised, double-blind, placebo-controlled, phase 1 study
Marc Gurwith, Michael Lock, Eve M. Taylor, Glenn Ishioka, Jeff Alexander, Tim Mayall, John E. Ervin, Richard N. Greenberg, Cynthia Strout, John J. Treanor, Richard Webby, Peter F. Wright
Research output: Contribution to journal › Article › peer-review
139Scopus
citations
Fingerprint
Dive into the research topics of 'Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: A Randomised, double-blind, placebo-controlled, phase 1 study'. Together they form a unique fingerprint.